(Q71093645)

English

How much can we rely on the level of prostate-specific antigen as an end point for evaluation of clinical trials? A word of caution!

scientific article published on 01 June 1996

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

8637038

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8637038%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 October 2019

editorial

0 references

title

How much can we rely on the level of prostate-specific antigen as an end point for evaluation of clinical trials? A word of caution! (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

8637038

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8637038%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 October 2019

author name string

M A Eisenberger

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed ID

8637038

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8637038%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 October 2019

W G Nelson

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

8637038

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8637038%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 October 2019

language of work or name

English

0 references

publication date

1 June 1996

1 reference

stated in

Europe PubMed Central

PubMed ID

8637038

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8637038%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 October 2019

published in

Journal of the National Cancer Institute

1 reference

stated in

Europe PubMed Central

PubMed ID

8637038

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8637038%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 October 2019

volume

88

1 reference

stated in

Europe PubMed Central

PubMed ID

8637038

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8637038%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 October 2019

page(s)

779-781

1 reference

stated in

Europe PubMed Central

PubMed ID

8637038

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8637038%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 October 2019

issue

12

1 reference

stated in

Europe PubMed Central

PubMed ID

8637038

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8637038%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 October 2019

Identifiers

DOI

10.1093/JNCI/88.12.779

1 reference

stated in

Europe PubMed Central

PubMed ID

8637038

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8637038%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference

Europe PubMed Central

PubMed ID

8637038

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8637038%20AND%20SRC:MED&resulttype=core&format=json

(Q71093645)

How much can we rely on the level of prostate-specific antigen as an end point for evaluation of clinical trials? A word of caution!

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)